bunge global sa - BG
BG
Close Chg Chg %
93.27 -0.43 -0.46%
Closed Market
92.84
-0.43 (0.46%)
Volume: 1.35M
Last Updated:
Dec 12, 2025, 3:59 PM EDT
Company Overview: bunge global sa - BG
BG Key Data
| Open $93.20 | Day Range 91.64 - 93.93 |
| 52 Week Range 67.40 - 99.55 | Market Cap $17.69B |
| Shares Outstanding 193.36M | Public Float 159.94M |
| Beta 0.78 | Rev. Per Employee N/A |
| P/E Ratio 10.02 | EPS $9.39 |
| Yield 298.06% | Dividend $0.70 |
| EX-DIVIDEND DATE Feb 17, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.32M |
BG Performance
| 1 Week | -0.84% | ||
| 1 Month | -3.30% | ||
| 3 Months | 13.75% | ||
| 1 Year | 12.33% | ||
| 5 Years | 40.58% |
BG Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
An error occurred while fetching the data.
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Bunge Global Sa - BG
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 59.15B | 67.22B | 59.53B | 53.11B | |
Sales Growth
| +42.81% | +13.65% | -11.44% | -10.78% | |
Cost of Goods Sold (COGS) incl D&A
| 54.04B | 63.18B | 55.62B | 49.62B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 424.00M | 404.00M | 451.00M | 468.00M | |
Depreciation
| 376.00M | 363.00M | 390.00M | 431.00M | |
Amortization of Intangibles
| 48.00M | 41.00M | 61.00M | 37.00M | |
COGS Growth
| +45.33% | +16.90% | -11.96% | -10.78% | |
Gross Income
| 5.11B | 4.05B | 3.91B | 3.49B | |
Gross Income Growth
| +20.70% | -20.75% | -3.31% | -10.83% | |
Gross Profit Margin
| +8.64% | +6.02% | +6.57% | +6.57% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 1.23B | 1.36B | 1.72B | 1.78B | |
Research & Development
| 33.00M | 33.00M | 35.00M | 30.00M | |
Other SG&A
| 1.20B | 1.33B | 1.68B | 1.75B | |
SGA Growth
| -9.13% | +10.62% | +25.71% | +3.50% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 1.63B | 511.00M | (786.00M) | 213.00M | |
EBIT after Unusual Expense
| 2.24B | 2.17B | 2.98B | 1.50B | |
Non Operating Income/Expense
| 595.00M | 264.00M | 455.00M | 376.00M | |
Non-Operating Interest Income
| 48.00M | 71.00M | 148.00M | 163.00M | |
Equity in Earnings of Affiliates
| 160.00M | 158.00M | 140.00M | (38.00M) | |
Interest Expense
| 274.00M | 370.00M | 388.00M | 353.00M | |
Interest Expense Growth
| -1.79% | +35.04% | +4.86% | -9.02% | |
Gross Interest Expense
| 276.00M | 373.00M | 407.00M | 393.00M | |
Interest Capitalized
| 2.00M | 3.00M | 19.00M | 40.00M | |
Pretax Income
| 2.56B | 2.07B | 3.05B | 1.52B | |
Pretax Income Growth
| +81.53% | -19.45% | +47.68% | -50.05% | |
Pretax Margin
| +4.34% | +3.07% | +5.12% | +2.87% | |
Income Tax
| 398.00M | 388.00M | 714.00M | 336.00M | |
Income Tax - Current - Domestic
| 169.00M | 217.00M | 218.00M | 107.00M | |
Income Tax - Current - Foreign
| 501.00M | 290.00M | 497.00M | 239.00M | |
Income Tax - Deferred - Domestic
| 10.00M | 29.00M | 46.00M | 18.00M | |
Income Tax - Deferred - Foreign
| (282.00M) | (148.00M) | (47.00M) | (28.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 160.00M | 158.00M | 140.00M | (38.00M) | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 2.17B | 1.68B | 2.34B | 1.19B | |
Minority Interest Expense
| 89.00M | 68.00M | 94.00M | 51.00M | |
Net Income
| 2.08B | 1.61B | 2.24B | 1.14B | |
Net Income Growth
| +79.91% | -22.52% | +39.32% | -49.31% | |
Net Margin Growth
| +3.51% | +2.39% | +3.77% | +2.14% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 2.08B | 1.61B | 2.24B | 1.14B | |
Preferred Dividends
| - | - | - | 34.00M | - |
Net Income Available to Common
| 2.04B | 1.61B | 2.24B | 1.14B | |
EPS (Basic)
| 14.4949 | 10.8263 | 15.0735 | 8.0902 | |
EPS (Basic) Growth
| +81.92% | -25.31% | +39.23% | -46.33% | |
Basic Shares Outstanding
| 141.02M | 148.71M | 148.80M | 140.54M | |
EPS (Diluted)
| 13.6382 | 10.5136 | 14.8752 | 7.9945 | |
EPS (Diluted) Growth
| +82.11% | -22.91% | +41.49% | -46.26% | |
Diluted Shares Outstanding
| 152.37M | 153.13M | 150.79M | 142.22M | |
EBITDA
| 4.30B | 3.09B | 2.65B | 2.18B | |
EBITDA Growth
| +29.97% | -28.18% | -14.19% | -17.63% | |
EBITDA Margin
| +7.27% | +4.59% | +4.45% | +4.11% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 110.556 | |
| Number of Ratings | 11 | Current Quarters Estimate | 1.904 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 7.464 | |
| Last Quarter’s Earnings | 2.27 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 9.19 | Next Fiscal Year Estimate | 8.70 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 7 | 4 | 8 | 8 |
| Mean Estimate | 1.90 | 1.73 | 7.46 | 8.70 |
| High Estimates | 2.01 | 2.21 | 7.54 | 9.25 |
| Low Estimate | 1.85 | 1.38 | 7.40 | 7.38 |
| Coefficient of Variance | 3.20 | 20.20 | 0.62 | 6.88 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 7 |
| OVERWEIGHT | 3 | 3 | 0 |
| HOLD | 2 | 2 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Bunge Global Sa - BG
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Bunge Global Sa - BG
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 4, 2025 | Eliane Aleixo L. de Andrade Director | 6,543 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 631,203.21 |
| Dec 4, 2025 | Kellie Sears Chief Human Resources Officer | 25,528 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 2,462,686.16 |
| Dec 4, 2025 | Christos Dimopoulos Executive VP, Global Markets | 104,744 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 10,104,653.68 |
| Dec 4, 2025 | Markus Walt Director | 2,197 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 211,944.59 |
| Dec 4, 2025 | Monica H. Mcgurk Director | 6,057 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 584,318.79 |
| Dec 4, 2025 | Adrian Gustavo Isman Director | 2,197 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 211,944.59 |
| Dec 4, 2025 | John W. Neppl Chief Financial Officer | 137,754 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 13,289,128.38 |
| Dec 4, 2025 | David William Mattiske Co-Chief Operating Officer | 153,875 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 14,844,321.25 |
| Dec 4, 2025 | Julio Garros Co-Chief Operating Officer | 124,127 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 11,974,531.69 |
| Dec 4, 2025 | Kenneth Michael Simril Director | 8,783 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 847,296.01 |
| Dec 4, 2025 | Gregory A. Heckman Chief Executive Officer; Director | 279,243 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 26,938,572.21 |
| Dec 4, 2025 | Christopher Mahoney Director | 7,197 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 694,294.59 |
| Dec 4, 2025 | Carol Martha Browner Director | 29,584 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 2,853,968.48 |
| Dec 4, 2025 | Joseph A. Podwika Chief Legal Officer | 85,504 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 8,248,570.88 |
| Dec 4, 2025 | Anne Jensen Director | 2,197 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 211,944.59 |
| Dec 4, 2025 | Henry Ward Winship Director | 33,442 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 3,226,149.74 |
| Dec 4, 2025 | Jerry Mathews Simmons Controller, Principal Actg Off | 56,162 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 5,417,948.14 |
| Dec 4, 2025 | Mark N. Zenuk Director | 21,871 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 2,109,895.37 |
| Dec 4, 2025 | Linda P. Jojo Director | 2,571 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $96.47 per share | 248,024.37 |
| May 20, 2025 | Kenneth Michael Simril Director | 8,722 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Bunge Global Sa in the News
Bunge, Viterra to merge to create global agribusiness giant
Bunge will buy Viterra for $8.2 billion. The acquisition will come alongside a $2 billion stock buyback and will merge ownership through a stock and cash deal.
Calls to boycott McDonald's, other brands in wake of Russia's invasion of Ukraine
Major global brands, including McDonald's Corp, PepsiCo Inc. and the Estee Lauder Cos Inc. should consider pausing their operations in Russia, New York state's pension fund chief wrote in letters to several companies on Friday.

